nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—ABCC4—Methotrexate—bone cancer	0.302	0.615	CbGbCtD
Oseltamivir—SLC22A8—Methotrexate—bone cancer	0.189	0.385	CbGbCtD
Oseltamivir—NEU1—Asparagine N-linked glycosylation—MOGS—bone cancer	0.0195	0.122	CbGpPWpGaD
Oseltamivir—NEU2—Asparagine N-linked glycosylation—MOGS—bone cancer	0.0148	0.0927	CbGpPWpGaD
Oseltamivir—CES1—Irinotecan Pathway—CYP3A4—bone cancer	0.0125	0.0785	CbGpPWpGaD
Oseltamivir—NEU1—Post-translational protein modification—MOGS—bone cancer	0.0101	0.0633	CbGpPWpGaD
Oseltamivir—ABCC4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00989	0.0621	CbGpPWpGaD
Oseltamivir—NEU2—Post-translational protein modification—MOGS—bone cancer	0.00764	0.048	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—DHFR—bone cancer	0.00743	0.0466	CbGpPWpGaD
Oseltamivir—ABCC4—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00578	0.0363	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—MOGS—bone cancer	0.00478	0.03	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—BCOR—bone cancer	0.00415	0.026	CbGpPWpGaD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—DHFR—bone cancer	0.00401	0.0252	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—DHFR—bone cancer	0.00394	0.0247	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—MOGS—bone cancer	0.00363	0.0228	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—TUBB4B—bone cancer	0.00262	0.0165	CbGpPWpGaD
Oseltamivir—Blood disorder—Epirubicin—bone cancer	0.00244	0.00697	CcSEcCtD
Oseltamivir—Otitis media—Doxorubicin—bone cancer	0.00242	0.00692	CcSEcCtD
Oseltamivir—Bone disorder—Methotrexate—bone cancer	0.00241	0.00689	CcSEcCtD
Oseltamivir—Delirium—Epirubicin—bone cancer	0.00237	0.00677	CcSEcCtD
Oseltamivir—Herpes simplex—Methotrexate—bone cancer	0.00236	0.00675	CcSEcCtD
Oseltamivir—Hepatic enzyme increased—Methotrexate—bone cancer	0.0023	0.00658	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—TUBB2A—bone cancer	0.00226	0.0142	CbGpPWpGaD
Oseltamivir—Blood disorder—Doxorubicin—bone cancer	0.00226	0.00645	CcSEcCtD
Oseltamivir—Bone disorder—Epirubicin—bone cancer	0.00226	0.00645	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NDUFA12—bone cancer	0.00226	0.0142	CbGpPWpGaD
Oseltamivir—Herpes simplex—Epirubicin—bone cancer	0.00221	0.00632	CcSEcCtD
Oseltamivir—Delirium—Doxorubicin—bone cancer	0.00219	0.00627	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—PLAU—bone cancer	0.00219	0.0137	CbGpPWpGaD
Oseltamivir—Conjunctivitis—Cisplatin—bone cancer	0.00216	0.00617	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Cisplatin—bone cancer	0.0021	0.006	CcSEcCtD
Oseltamivir—Bone disorder—Doxorubicin—bone cancer	0.00209	0.00597	CcSEcCtD
Oseltamivir—Herpes simplex—Doxorubicin—bone cancer	0.00205	0.00585	CcSEcCtD
Oseltamivir—Hepatocellular injury—Epirubicin—bone cancer	0.00204	0.00582	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—SPARC—bone cancer	0.00202	0.0127	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—TUBB4B—bone cancer	0.00199	0.0125	CbGpPWpGaD
Oseltamivir—Influenza like illness—Epirubicin—bone cancer	0.00198	0.00566	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.00192	0.0121	CbGpPWpGaD
Oseltamivir—Visual impairment—Cisplatin—bone cancer	0.00192	0.00549	CcSEcCtD
Oseltamivir—Hepatocellular injury—Doxorubicin—bone cancer	0.00189	0.00539	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NT5C3A—bone cancer	0.00187	0.0117	CbGpPWpGaD
Oseltamivir—Eye disorder—Cisplatin—bone cancer	0.00186	0.00532	CcSEcCtD
Oseltamivir—Lymphadenopathy—Methotrexate—bone cancer	0.00185	0.0053	CcSEcCtD
Oseltamivir—Cardiac disorder—Cisplatin—bone cancer	0.00185	0.00529	CcSEcCtD
Oseltamivir—Influenza like illness—Doxorubicin—bone cancer	0.00183	0.00523	CcSEcCtD
Oseltamivir—Diabetes mellitus—Methotrexate—bone cancer	0.00182	0.00519	CcSEcCtD
Oseltamivir—Immune system disorder—Cisplatin—bone cancer	0.0018	0.00514	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—RB1—bone cancer	0.0018	0.0113	CbGpPWpGaD
Oseltamivir—Mediastinal disorder—Cisplatin—bone cancer	0.0018	0.00513	CcSEcCtD
Oseltamivir—Arrhythmia—Cisplatin—bone cancer	0.00178	0.00509	CcSEcCtD
Oseltamivir—Hepatic failure—Methotrexate—bone cancer	0.00176	0.00503	CcSEcCtD
Oseltamivir—Lymphadenopathy—Epirubicin—bone cancer	0.00174	0.00496	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—TUBB2A—bone cancer	0.00171	0.0108	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NDUFA12—bone cancer	0.00171	0.0107	CbGpPWpGaD
Oseltamivir—Diabetes mellitus—Epirubicin—bone cancer	0.0017	0.00486	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Epirubicin—bone cancer	0.00169	0.00484	CcSEcCtD
Oseltamivir—Visual disturbance—Methotrexate—bone cancer	0.00167	0.00477	CcSEcCtD
Oseltamivir—CES1—Fluoropyrimidine Activity—TP53—bone cancer	0.00166	0.0104	CbGpPWpGaD
Oseltamivir—Eczema—Epirubicin—bone cancer	0.00165	0.0047	CcSEcCtD
Oseltamivir—Hepatic failure—Epirubicin—bone cancer	0.00165	0.0047	CcSEcCtD
Oseltamivir—Eye pain—Epirubicin—bone cancer	0.00164	0.00468	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GSTP1—bone cancer	0.00164	0.0103	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—TGFBR2—bone cancer	0.00164	0.0103	CbGpPWpGaD
Oseltamivir—Anaphylactoid reaction—Methotrexate—bone cancer	0.00163	0.00467	CcSEcCtD
Oseltamivir—Lymphadenopathy—Doxorubicin—bone cancer	0.00161	0.00459	CcSEcCtD
Oseltamivir—Anaemia—Cisplatin—bone cancer	0.0016	0.00458	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—EIF2S1—bone cancer	0.00158	0.0099	CbGpPWpGaD
Oseltamivir—Diabetes mellitus—Doxorubicin—bone cancer	0.00157	0.0045	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Doxorubicin—bone cancer	0.00157	0.00448	CcSEcCtD
Oseltamivir—Anaphylactoid reaction—Epirubicin—bone cancer	0.00153	0.00437	CcSEcCtD
Oseltamivir—Hepatic failure—Doxorubicin—bone cancer	0.00152	0.00435	CcSEcCtD
Oseltamivir—Eczema—Doxorubicin—bone cancer	0.00152	0.00435	CcSEcCtD
Oseltamivir—Eye pain—Doxorubicin—bone cancer	0.00152	0.00433	CcSEcCtD
Oseltamivir—Convulsion—Cisplatin—bone cancer	0.0015	0.0043	CcSEcCtD
Oseltamivir—Pain in extremity—Epirubicin—bone cancer	0.00148	0.00423	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.00148	0.00423	CcSEcCtD
Oseltamivir—Myalgia—Cisplatin—bone cancer	0.00148	0.00422	CcSEcCtD
Oseltamivir—Anxiety—Cisplatin—bone cancer	0.00147	0.00421	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00147	0.00419	CcSEcCtD
Oseltamivir—Liver function test abnormal—Methotrexate—bone cancer	0.00146	0.00417	CcSEcCtD
Oseltamivir—Face oedema—Epirubicin—bone cancer	0.00143	0.00408	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00142	0.00407	CcSEcCtD
Oseltamivir—Anaphylactic shock—Cisplatin—bone cancer	0.00142	0.00405	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NT5C3A—bone cancer	0.00142	0.00889	CbGpPWpGaD
Oseltamivir—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00142	0.00404	CcSEcCtD
Oseltamivir—Infection—Cisplatin—bone cancer	0.00141	0.00402	CcSEcCtD
Oseltamivir—Nervous system disorder—Cisplatin—bone cancer	0.00139	0.00397	CcSEcCtD
Oseltamivir—Thrombocytopenia—Cisplatin—bone cancer	0.00139	0.00396	CcSEcCtD
Oseltamivir—Skin disorder—Cisplatin—bone cancer	0.00138	0.00393	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00137	0.00391	CcSEcCtD
Oseltamivir—Pain in extremity—Doxorubicin—bone cancer	0.00137	0.00391	CcSEcCtD
Oseltamivir—Asthma—Methotrexate—bone cancer	0.00137	0.0039	CcSEcCtD
Oseltamivir—Liver function test abnormal—Epirubicin—bone cancer	0.00137	0.0039	CcSEcCtD
Oseltamivir—Abdominal pain upper—Epirubicin—bone cancer	0.00135	0.00386	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00133	0.00381	CcSEcCtD
Oseltamivir—Nasopharyngitis—Epirubicin—bone cancer	0.00132	0.00378	CcSEcCtD
Oseltamivir—Face oedema—Doxorubicin—bone cancer	0.00132	0.00378	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00129	0.00369	CcSEcCtD
Oseltamivir—Influenza—Epirubicin—bone cancer	0.00128	0.00365	CcSEcCtD
Oseltamivir—Asthma—Epirubicin—bone cancer	0.00128	0.00365	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Methotrexate—bone cancer	0.00127	0.00363	CcSEcCtD
Oseltamivir—Liver function test abnormal—Doxorubicin—bone cancer	0.00126	0.00361	CcSEcCtD
Oseltamivir—Abdominal pain upper—Doxorubicin—bone cancer	0.00125	0.00357	CcSEcCtD
Oseltamivir—Angina pectoris—Epirubicin—bone cancer	0.00125	0.00356	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00123	0.00352	CcSEcCtD
Oseltamivir—Bronchitis—Epirubicin—bone cancer	0.00123	0.00351	CcSEcCtD
Oseltamivir—Pneumonia—Methotrexate—bone cancer	0.00123	0.0035	CcSEcCtD
Oseltamivir—Nasopharyngitis—Doxorubicin—bone cancer	0.00122	0.0035	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Cisplatin—bone cancer	0.00122	0.00349	CcSEcCtD
Oseltamivir—Infestation NOS—Methotrexate—bone cancer	0.00122	0.00348	CcSEcCtD
Oseltamivir—Infestation—Methotrexate—bone cancer	0.00122	0.00348	CcSEcCtD
Oseltamivir—Pain—Cisplatin—bone cancer	0.00121	0.00346	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00121	0.00345	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—EIF2S1—bone cancer	0.0012	0.00751	CbGpPWpGaD
Oseltamivir—Upper respiratory tract infection—Epirubicin—bone cancer	0.00119	0.0034	CcSEcCtD
Oseltamivir—Conjunctivitis—Methotrexate—bone cancer	0.00118	0.00338	CcSEcCtD
Oseltamivir—Influenza—Doxorubicin—bone cancer	0.00118	0.00338	CcSEcCtD
Oseltamivir—Asthma—Doxorubicin—bone cancer	0.00118	0.00338	CcSEcCtD
Oseltamivir—Feeling abnormal—Cisplatin—bone cancer	0.00117	0.00333	CcSEcCtD
Oseltamivir—Angina pectoris—Doxorubicin—bone cancer	0.00115	0.00329	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Methotrexate—bone cancer	0.00115	0.00329	CcSEcCtD
Oseltamivir—Epistaxis—Methotrexate—bone cancer	0.00115	0.00328	CcSEcCtD
Oseltamivir—Pneumonia—Epirubicin—bone cancer	0.00115	0.00328	CcSEcCtD
Oseltamivir—Infestation NOS—Epirubicin—bone cancer	0.00114	0.00326	CcSEcCtD
Oseltamivir—Infestation—Epirubicin—bone cancer	0.00114	0.00326	CcSEcCtD
Oseltamivir—Bronchitis—Doxorubicin—bone cancer	0.00114	0.00325	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00113	0.00323	CcSEcCtD
Oseltamivir—Body temperature increased—Cisplatin—bone cancer	0.00112	0.0032	CcSEcCtD
Oseltamivir—Jaundice—Epirubicin—bone cancer	0.00111	0.00318	CcSEcCtD
Oseltamivir—Conjunctivitis—Epirubicin—bone cancer	0.00111	0.00317	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Doxorubicin—bone cancer	0.0011	0.00314	CcSEcCtD
Oseltamivir—Hepatitis—Methotrexate—bone cancer	0.00109	0.00313	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Epirubicin—bone cancer	0.00108	0.00308	CcSEcCtD
Oseltamivir—Epistaxis—Epirubicin—bone cancer	0.00108	0.00307	CcSEcCtD
Oseltamivir—Sinusitis—Epirubicin—bone cancer	0.00107	0.00306	CcSEcCtD
Oseltamivir—Pneumonia—Doxorubicin—bone cancer	0.00106	0.00303	CcSEcCtD
Oseltamivir—Infestation—Doxorubicin—bone cancer	0.00106	0.00301	CcSEcCtD
Oseltamivir—Infestation NOS—Doxorubicin—bone cancer	0.00106	0.00301	CcSEcCtD
Oseltamivir—Visual impairment—Methotrexate—bone cancer	0.00105	0.00301	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00105	0.00299	CcSEcCtD
Oseltamivir—Hypersensitivity—Cisplatin—bone cancer	0.00104	0.00298	CcSEcCtD
Oseltamivir—Erythema multiforme—Methotrexate—bone cancer	0.00103	0.00296	CcSEcCtD
Oseltamivir—Jaundice—Doxorubicin—bone cancer	0.00103	0.00294	CcSEcCtD
Oseltamivir—Conjunctivitis—Doxorubicin—bone cancer	0.00103	0.00293	CcSEcCtD
Oseltamivir—Hepatitis—Epirubicin—bone cancer	0.00102	0.00293	CcSEcCtD
Oseltamivir—Eye disorder—Methotrexate—bone cancer	0.00102	0.00292	CcSEcCtD
Oseltamivir—Asthenia—Cisplatin—bone cancer	0.00102	0.0029	CcSEcCtD
Oseltamivir—Cardiac disorder—Methotrexate—bone cancer	0.00102	0.0029	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Doxorubicin—bone cancer	0.000998	0.00285	CcSEcCtD
Oseltamivir—Epistaxis—Doxorubicin—bone cancer	0.000996	0.00284	CcSEcCtD
Oseltamivir—Sinusitis—Doxorubicin—bone cancer	0.00099	0.00283	CcSEcCtD
Oseltamivir—Immune system disorder—Methotrexate—bone cancer	0.000988	0.00282	CcSEcCtD
Oseltamivir—Visual impairment—Epirubicin—bone cancer	0.000987	0.00282	CcSEcCtD
Oseltamivir—Mediastinal disorder—Methotrexate—bone cancer	0.000986	0.00282	CcSEcCtD
Oseltamivir—Diarrhoea—Cisplatin—bone cancer	0.000969	0.00277	CcSEcCtD
Oseltamivir—Erythema multiforme—Epirubicin—bone cancer	0.000968	0.00277	CcSEcCtD
Oseltamivir—Mental disorder—Methotrexate—bone cancer	0.000959	0.00274	CcSEcCtD
Oseltamivir—Eye disorder—Epirubicin—bone cancer	0.000957	0.00273	CcSEcCtD
Oseltamivir—Cardiac disorder—Epirubicin—bone cancer	0.00095	0.00271	CcSEcCtD
Oseltamivir—Hepatitis—Doxorubicin—bone cancer	0.000948	0.00271	CcSEcCtD
Oseltamivir—Immune system disorder—Epirubicin—bone cancer	0.000925	0.00264	CcSEcCtD
Oseltamivir—Mediastinal disorder—Epirubicin—bone cancer	0.000923	0.00264	CcSEcCtD
Oseltamivir—Back pain—Methotrexate—bone cancer	0.000921	0.00263	CcSEcCtD
Oseltamivir—Arrhythmia—Epirubicin—bone cancer	0.000915	0.00261	CcSEcCtD
Oseltamivir—Visual impairment—Doxorubicin—bone cancer	0.000913	0.00261	CcSEcCtD
Oseltamivir—Vomiting—Cisplatin—bone cancer	0.000901	0.00257	CcSEcCtD
Oseltamivir—Mental disorder—Epirubicin—bone cancer	0.000897	0.00256	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	0.000897	0.00563	CbGpPWpGaD
Oseltamivir—Erythema multiforme—Doxorubicin—bone cancer	0.000896	0.00256	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000896	0.00562	CbGpPWpGaD
Oseltamivir—Rash—Cisplatin—bone cancer	0.000893	0.00255	CcSEcCtD
Oseltamivir—Dermatitis—Cisplatin—bone cancer	0.000892	0.00255	CcSEcCtD
Oseltamivir—Eye disorder—Doxorubicin—bone cancer	0.000886	0.00253	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GSTP1—bone cancer	0.000885	0.00555	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFBR2—bone cancer	0.000885	0.00555	CbGpPWpGaD
Oseltamivir—Anaemia—Methotrexate—bone cancer	0.00088	0.00251	CcSEcCtD
Oseltamivir—Cardiac disorder—Doxorubicin—bone cancer	0.000879	0.00251	CcSEcCtD
Oseltamivir—Back pain—Epirubicin—bone cancer	0.000862	0.00246	CcSEcCtD
Oseltamivir—Immune system disorder—Doxorubicin—bone cancer	0.000856	0.00244	CcSEcCtD
Oseltamivir—Vertigo—Methotrexate—bone cancer	0.000856	0.00244	CcSEcCtD
Oseltamivir—Mediastinal disorder—Doxorubicin—bone cancer	0.000854	0.00244	CcSEcCtD
Oseltamivir—Arrhythmia—Doxorubicin—bone cancer	0.000846	0.00242	CcSEcCtD
Oseltamivir—Nausea—Cisplatin—bone cancer	0.000842	0.0024	CcSEcCtD
Oseltamivir—Cough—Methotrexate—bone cancer	0.000831	0.00237	CcSEcCtD
Oseltamivir—Mental disorder—Doxorubicin—bone cancer	0.00083	0.00237	CcSEcCtD
Oseltamivir—Convulsion—Methotrexate—bone cancer	0.000825	0.00236	CcSEcCtD
Oseltamivir—Anaemia—Epirubicin—bone cancer	0.000824	0.00235	CcSEcCtD
Oseltamivir—Agitation—Epirubicin—bone cancer	0.000819	0.00234	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000819	0.00514	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ENO2—bone cancer	0.000819	0.00514	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000816	0.00512	CbGpPWpGaD
Oseltamivir—Arthralgia—Methotrexate—bone cancer	0.000811	0.00232	CcSEcCtD
Oseltamivir—Myalgia—Methotrexate—bone cancer	0.000811	0.00232	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000805	0.0023	CcSEcCtD
Oseltamivir—Vertigo—Epirubicin—bone cancer	0.000801	0.00229	CcSEcCtD
Oseltamivir—Back pain—Doxorubicin—bone cancer	0.000798	0.00228	CcSEcCtD
Oseltamivir—Confusional state—Methotrexate—bone cancer	0.000784	0.00224	CcSEcCtD
Oseltamivir—Cough—Epirubicin—bone cancer	0.000778	0.00222	CcSEcCtD
Oseltamivir—Anaphylactic shock—Methotrexate—bone cancer	0.000777	0.00222	CcSEcCtD
Oseltamivir—Convulsion—Epirubicin—bone cancer	0.000772	0.00221	CcSEcCtD
Oseltamivir—Infection—Methotrexate—bone cancer	0.000772	0.00221	CcSEcCtD
Oseltamivir—Nervous system disorder—Methotrexate—bone cancer	0.000762	0.00218	CcSEcCtD
Oseltamivir—Anaemia—Doxorubicin—bone cancer	0.000762	0.00218	CcSEcCtD
Oseltamivir—Thrombocytopenia—Methotrexate—bone cancer	0.000761	0.00217	CcSEcCtD
Oseltamivir—NEU1—Metabolism—DHFR—bone cancer	0.000759	0.00477	CbGpPWpGaD
Oseltamivir—Myalgia—Epirubicin—bone cancer	0.000759	0.00217	CcSEcCtD
Oseltamivir—Arthralgia—Epirubicin—bone cancer	0.000759	0.00217	CcSEcCtD
Oseltamivir—Agitation—Doxorubicin—bone cancer	0.000758	0.00217	CcSEcCtD
Oseltamivir—Anxiety—Epirubicin—bone cancer	0.000756	0.00216	CcSEcCtD
Oseltamivir—Skin disorder—Methotrexate—bone cancer	0.000755	0.00216	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000754	0.00215	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000743	0.00466	CbGpPWpGaD
Oseltamivir—Vertigo—Doxorubicin—bone cancer	0.000741	0.00212	CcSEcCtD
Oseltamivir—Confusional state—Epirubicin—bone cancer	0.000734	0.0021	CcSEcCtD
Oseltamivir—Anaphylactic shock—Epirubicin—bone cancer	0.000728	0.00208	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000726	0.00455	CbGpPWpGaD
Oseltamivir—Infection—Epirubicin—bone cancer	0.000723	0.00206	CcSEcCtD
Oseltamivir—Cough—Doxorubicin—bone cancer	0.00072	0.00206	CcSEcCtD
Oseltamivir—Convulsion—Doxorubicin—bone cancer	0.000715	0.00204	CcSEcCtD
Oseltamivir—Nervous system disorder—Epirubicin—bone cancer	0.000714	0.00204	CcSEcCtD
Oseltamivir—Thrombocytopenia—Epirubicin—bone cancer	0.000712	0.00203	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GNA11—bone cancer	0.00071	0.00445	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000708	0.00202	CcSEcCtD
Oseltamivir—Skin disorder—Epirubicin—bone cancer	0.000707	0.00202	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000704	0.00442	CbGpPWpGaD
Oseltamivir—Insomnia—Methotrexate—bone cancer	0.000703	0.00201	CcSEcCtD
Oseltamivir—Myalgia—Doxorubicin—bone cancer	0.000702	0.00201	CcSEcCtD
Oseltamivir—Arthralgia—Doxorubicin—bone cancer	0.000702	0.00201	CcSEcCtD
Oseltamivir—Anxiety—Doxorubicin—bone cancer	0.0007	0.002	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000697	0.00199	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000696	0.00437	CbGpPWpGaD
Oseltamivir—Dyspepsia—Methotrexate—bone cancer	0.000684	0.00195	CcSEcCtD
Oseltamivir—Confusional state—Doxorubicin—bone cancer	0.000679	0.00194	CcSEcCtD
Oseltamivir—Anaphylactic shock—Doxorubicin—bone cancer	0.000673	0.00192	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Methotrexate—bone cancer	0.000671	0.00192	CcSEcCtD
Oseltamivir—Fatigue—Methotrexate—bone cancer	0.00067	0.00191	CcSEcCtD
Oseltamivir—Infection—Doxorubicin—bone cancer	0.000669	0.00191	CcSEcCtD
Oseltamivir—Pain—Methotrexate—bone cancer	0.000665	0.0019	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000663	0.00189	CcSEcCtD
Oseltamivir—Nervous system disorder—Doxorubicin—bone cancer	0.00066	0.00189	CcSEcCtD
Oseltamivir—Thrombocytopenia—Doxorubicin—bone cancer	0.000659	0.00188	CcSEcCtD
Oseltamivir—Insomnia—Epirubicin—bone cancer	0.000658	0.00188	CcSEcCtD
Oseltamivir—Skin disorder—Doxorubicin—bone cancer	0.000654	0.00187	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—MMP2—bone cancer	0.000646	0.00405	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP3A4—bone cancer	0.000643	0.00404	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Methotrexate—bone cancer	0.000641	0.00183	CcSEcCtD
Oseltamivir—Dyspepsia—Epirubicin—bone cancer	0.00064	0.00183	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.00064	0.00402	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Methotrexate—bone cancer	0.000636	0.00182	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Epirubicin—bone cancer	0.000628	0.00179	CcSEcCtD
Oseltamivir—Fatigue—Epirubicin—bone cancer	0.000627	0.00179	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000626	0.00393	CbGpPWpGaD
Oseltamivir—Pain—Epirubicin—bone cancer	0.000622	0.00178	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ENO2—bone cancer	0.00062	0.00389	CbGpPWpGaD
Oseltamivir—Urticaria—Methotrexate—bone cancer	0.000618	0.00176	CcSEcCtD
Oseltamivir—Abdominal pain—Methotrexate—bone cancer	0.000615	0.00176	CcSEcCtD
Oseltamivir—Body temperature increased—Methotrexate—bone cancer	0.000615	0.00176	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000613	0.00175	CcSEcCtD
Oseltamivir—Insomnia—Doxorubicin—bone cancer	0.000609	0.00174	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000601	0.00377	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Epirubicin—bone cancer	0.0006	0.00171	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Epirubicin—bone cancer	0.000595	0.0017	CcSEcCtD
Oseltamivir—Dyspepsia—Doxorubicin—bone cancer	0.000593	0.00169	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000581	0.00166	CcSEcCtD
Oseltamivir—Fatigue—Doxorubicin—bone cancer	0.00058	0.00166	CcSEcCtD
Oseltamivir—Urticaria—Epirubicin—bone cancer	0.000578	0.00165	CcSEcCtD
Oseltamivir—Pain—Doxorubicin—bone cancer	0.000576	0.00164	CcSEcCtD
Oseltamivir—NEU2—Metabolism—DHFR—bone cancer	0.000575	0.00361	CbGpPWpGaD
Oseltamivir—Abdominal pain—Epirubicin—bone cancer	0.000575	0.00164	CcSEcCtD
Oseltamivir—Body temperature increased—Epirubicin—bone cancer	0.000575	0.00164	CcSEcCtD
Oseltamivir—Hypersensitivity—Methotrexate—bone cancer	0.000573	0.00164	CcSEcCtD
Oseltamivir—Asthenia—Methotrexate—bone cancer	0.000558	0.00159	CcSEcCtD
Oseltamivir—Feeling abnormal—Doxorubicin—bone cancer	0.000555	0.00158	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Doxorubicin—bone cancer	0.00055	0.00157	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GSTP1—bone cancer	0.00055	0.00345	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GNA11—bone cancer	0.000538	0.00338	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Epirubicin—bone cancer	0.000536	0.00153	CcSEcCtD
Oseltamivir—Urticaria—Doxorubicin—bone cancer	0.000535	0.00153	CcSEcCtD
Oseltamivir—Body temperature increased—Doxorubicin—bone cancer	0.000532	0.00152	CcSEcCtD
Oseltamivir—Abdominal pain—Doxorubicin—bone cancer	0.000532	0.00152	CcSEcCtD
Oseltamivir—Diarrhoea—Methotrexate—bone cancer	0.000532	0.00152	CcSEcCtD
Oseltamivir—Asthenia—Epirubicin—bone cancer	0.000522	0.00149	CcSEcCtD
Oseltamivir—Dizziness—Methotrexate—bone cancer	0.000514	0.00147	CcSEcCtD
Oseltamivir—Diarrhoea—Epirubicin—bone cancer	0.000498	0.00142	CcSEcCtD
Oseltamivir—Hypersensitivity—Doxorubicin—bone cancer	0.000496	0.00142	CcSEcCtD
Oseltamivir—Vomiting—Methotrexate—bone cancer	0.000494	0.00141	CcSEcCtD
Oseltamivir—Rash—Methotrexate—bone cancer	0.00049	0.0014	CcSEcCtD
Oseltamivir—Dermatitis—Methotrexate—bone cancer	0.00049	0.0014	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—MMP2—bone cancer	0.000489	0.00307	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP3A4—bone cancer	0.000488	0.00306	CbGpPWpGaD
Oseltamivir—Headache—Methotrexate—bone cancer	0.000487	0.00139	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000485	0.00304	CbGpPWpGaD
Oseltamivir—Asthenia—Doxorubicin—bone cancer	0.000483	0.00138	CcSEcCtD
Oseltamivir—Dizziness—Epirubicin—bone cancer	0.000481	0.00137	CcSEcCtD
Oseltamivir—Vomiting—Epirubicin—bone cancer	0.000463	0.00132	CcSEcCtD
Oseltamivir—Nausea—Methotrexate—bone cancer	0.000462	0.00132	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—SPARC—bone cancer	0.000462	0.0029	CbGpPWpGaD
Oseltamivir—Diarrhoea—Doxorubicin—bone cancer	0.000461	0.00132	CcSEcCtD
Oseltamivir—Rash—Epirubicin—bone cancer	0.000459	0.00131	CcSEcCtD
Oseltamivir—Dermatitis—Epirubicin—bone cancer	0.000458	0.00131	CcSEcCtD
Oseltamivir—Headache—Epirubicin—bone cancer	0.000456	0.0013	CcSEcCtD
Oseltamivir—Dizziness—Doxorubicin—bone cancer	0.000445	0.00127	CcSEcCtD
Oseltamivir—Nausea—Epirubicin—bone cancer	0.000432	0.00123	CcSEcCtD
Oseltamivir—Vomiting—Doxorubicin—bone cancer	0.000428	0.00122	CcSEcCtD
Oseltamivir—Rash—Doxorubicin—bone cancer	0.000424	0.00121	CcSEcCtD
Oseltamivir—Dermatitis—Doxorubicin—bone cancer	0.000424	0.00121	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—GNA11—bone cancer	0.000422	0.00265	CbGpPWpGaD
Oseltamivir—Headache—Doxorubicin—bone cancer	0.000422	0.0012	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GSTP1—bone cancer	0.000417	0.00262	CbGpPWpGaD
Oseltamivir—Nausea—Doxorubicin—bone cancer	0.0004	0.00114	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—IL3—bone cancer	0.000383	0.0024	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTGS2—bone cancer	0.000285	0.00179	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PLAU—bone cancer	0.000251	0.00158	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PTGS2—bone cancer	0.000216	0.00136	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—bone cancer	0.000101	0.000633	CbGpPWpGaD
